Browsing: Longevity Risk
Longevity and Mortality Investor’s coverage of bulk purchase annuity transactions. We are a leading source globally for longevity risk analysis, commentary and insights.
The longevity economy is multi-faceted, with a range of investment opportunities available that can impact longevity in different ways. Greg Winterton spoke to Sergey Jakimov, Founding Partner of venture capital firm LongeVC, to get his views on both the space overall, and how LongeVC sees it, and therefore, approaches it in our latest Q&A.
New research from Standard Life suggests that the current push for bulk purchase annuity buy-ins in the UK pension risk transfer market looks set to continue as 40% of defined benefit trustees that are targeting BPA as their end-game strategy expect to approach an insurer in the next 12 months.
TPT Retirement Solutions has announced its intention to launch a new Defined Benefit pension superfund designed to support run-on. Both The Pensions Regulator (TPR) and the Department for Work and Pensions (DWP) have expressed their support for superfunds, which offer schemes an alternative endgame solution.
MetLife’s 2025 Pension Risk Transfer Poll reveals 94% of plan sponsors with de-risking goals plan to fully divest pension liabilities – most within five years.
The most recent mortality monitor from the Continuous Mortality Investigation shows that overall mortality in England and Wales in the third quarter of 2025 was lower than in any other quarter. The previous record low was for the third quarter of 2020, in the aftermath of the first wave of the Covid-19 pandemic.
The Trustees of the Ferno (UK) Limited Retirement and Death Benefits Scheme have agreed a c. £4m full scheme buy-in with Legal & General. The transaction was agreed in October 2025 and covers approximately 100 scheme members.
Canada Life has appointed Dominic Carpenter as Bulk Purchase Annuities Commercial & Strategy Director, a new role at the firm. Carpenter will lead the commercial development of Canada Life’s bulk annuities business and drive initiatives across commercial strategy, reinsurance and pricing to support its BPA growth ambitions.
Despite its growth and maturity in the past 25 years, the life settlement asset class remains a complicated one that requires deep analysis so that investors can understand it fully.
The increasing frequency and magnitude of cyber-attacks on British businesses have prompted the UK’s pensions industry to consider its own resilience, especially during de-risking processes when scheme members’ data is at a heightened state of vulnerability.
Under optimistic scenarios, new research from Swiss Re projects that GLP-1 medications could reduce all-cause mortality in the US by as much as 6.4% by 2045. But what will the impact be on the life settlement market?